CT guided interstitial high dose rate brachytherapy for recurrent malignant gliomas

被引:23
作者
Kolotas, C
Birn, G
Baltas, D
Rogge, B
Ulrich, P
Zamboglou, N
机构
[1] Stadt Kliniken Offenbach, Strahlenklin, D-63039 Offenbach, Germany
[2] Stadt Kliniken Offenbach, Neurochirurg Klin, D-63039 Offenbach, Germany
关键词
D O I
10.1259/bjr.72.860.10624349
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
This paper describes the technique and preliminary results of high dose rate (HDR) interstitial brachytherapy for recurrent grade III and grade IV gliomas. Although in the initial treatment of malignant gliomas brachytherapy has been shown to give better results than external beam therapy, this has previously always been with low dose rate (LDR) brachytherapy. Stereotactic frames are used for interstitial LDR brachytherapy but a CT image-guided technique does not require such a frame. The survival rates for our initial 53 patients do not significantly differ from LDR results. However, using HDR there are several advantages, including a much shorter treatment time with HDR than LDR and better patient comfort. HDR also allows better individualized optimization of the treatment than LDR.
引用
收藏
页码:805 / 808
页数:4
相关论文
共 14 条
[1]   A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy [J].
Baltas, D ;
Kolotas, C ;
Geramani, K ;
Mould, RF ;
Ioannidis, G ;
Kekchidi, M ;
Zamboglou, N .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 40 (02) :515-524
[2]  
CURRAN WJ, 1992, J NEURO-ONCOL, V12, P219
[3]  
Hayat K, 1997, Clin Oncol (R Coll Radiol), V9, P158, DOI 10.1016/S0936-6555(97)80072-6
[4]   ASSUMPTIONS IN THE RADIOTHERAPY OF GLIOBLASTOMA [J].
HOCHBERG, FH ;
PRUITT, A .
NEUROLOGY, 1980, 30 (09) :907-911
[5]  
KRISTIANSEN K, 1981, CANCER, V47, P649, DOI 10.1002/1097-0142(19810215)47:4<649::AID-CNCR2820470405>3.0.CO
[6]  
2-W
[7]   SURVIVAL AND QUALITY OF LIFE AFTER INTERSTITIAL IMPLANTATION OF REMOVABLE HIGH-ACTIVITY I-125 SOURCES FOR THE TREATMENT OF PATIENTS WITH RECURRENT MALIGNANT GLIOMAS [J].
LEIBEL, SA ;
GUTIN, PH ;
WARA, WM ;
SILVER, PS ;
LARSON, DA ;
EDWARDS, MSB ;
LAMB, SA ;
HAM, B ;
WEAVER, KA ;
BARNETT, C ;
PHILLIPS, TL .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (06) :1129-1139
[8]   SUPERIORITY OF POST-RADIOTHERAPY ADJUVANT CHEMOTHERAPY WITH CCNU, PROCARBAZINE, AND VINCRISTINE (PCV) OVER BCNU FOR ANAPLASTIC GLIOMAS - NCOG-6G61 FINAL REPORT [J].
LEVIN, VA ;
SILVER, P ;
HANNIGAN, J ;
WARA, WM ;
GUTIN, PH ;
DAVIS, RL ;
WILSON, CB .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 18 (02) :321-324
[9]   NATIONAL SURVEY OF PATTERNS OF CARE FOR BRAIN-TUMOR PATIENTS [J].
MAHALEY, MS ;
METTLIN, C ;
NATARAJAN, N ;
LAWS, ER ;
PEACE, BB .
JOURNAL OF NEUROSURGERY, 1989, 71 (06) :826-836
[10]  
NELSON D F, 1988, NCI (National Cancer Institute) Monographs, P279